how does tirzepatide compare to other diabetes medications Semaglutide vs πβοΈ Both are powerful for and weight loss, but tirzepatide's dual GIP + GLP-1 action may lead even greater weight loss and glucose control. Semaglutide offers π₯ Tirzepatide vs. Semaglutide β
Description
With commercial insurance that doesnt cover it, as low as $499/month
While not approved specifically for weight loss, clinical trials showed average weight reduction of 3-5% of body weight, making it the least potent option in this category for weight management

Standard insulin syringes have minimal dead space (0.5-2 units)

In addition, patients with a BMI of 27 or higher may be eligible for Tirzepatide treatment if they have weight-related conditions like hypertension, high cholesterol, sleep apnea, or type 2 diabetes
These effects are typically mild to moderate, most pronounced during the first 13 days after injection, and generally improve within 48 weeks as tolerance develops

Tirzepatide is an FDA-approved medication that has been evaluated in clinical trials and is considered to be both safe and effective for use in weight loss and type 2 diabetes